Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nutt

Showing results (131-140 of 179) with videos related to

Pageof 18
Sort By:
Psychopharmacology|February 4, 2018
The hidden therapist: evidence for a central role of music in psychedelic therapyMendel Kaelen, Bruna Giribaldi, Jordan Raine, et al.
Neuropharmacology|May 2, 2012
The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography studyMaria Andreina Mendez, Jamie Horder, Jim Myers, et al.
Nature Medicine|April 12, 2022
Increased global integration in the brain after psilocybin therapy for depressionRichard E Daws, Christopher Timmermann, Bruna Giribaldi, et al.
Trials|May 24, 2008
GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocolLaura Thomas, Jean Mulligan, Victoria Mason, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 4, 2015
A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based NomenclatureJoseph Zohar, Stephen Stahl, Hans-Jurgen Moller, et al.
Lancet (London, England)|July 24, 2010
Vienna Declaration: a call for evidence-based drug policiesEvan Wood, Dan Werb, Michel Kazatchkine, et al.
Journal of Psychopharmacology (Oxford, England)|July 16, 2019
Microdosing psychedelics: More questions than answers? An overview and suggestions for future researchKim Pc Kuypers, Livia Ng, David Erritzoe, et al.
EJNMMI Physics|March 10, 2016
Assessment of the quality of brain regions and neuroimaging metrics as biomarkers of Alzheimer's DiseaseTânia Faria Vaz, Filipa Lucena, Joana Pé-Leve, et al.
Brain : a Journal of Neurology|September 11, 2019
Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo11C-BU99008 PET studyHeather Wilson, George Dervenoulas, Gennaro Pagano, et al.
Journal of Psychopharmacology (Oxford, England)|July 5, 2019
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An updateSue Wilson, Kirstie Anderson, David Baldwin, et al.
Pageof 18

Showing results (131-140 of 179) with videos related to

Sort By:
Pageof 18
Psychopharmacology|February 4, 2018
The hidden therapist: evidence for a central role of music in psychedelic therapyMendel Kaelen, Bruna Giribaldi, Jordan Raine, et al.
Neuropharmacology|May 2, 2012
The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography studyMaria Andreina Mendez, Jamie Horder, Jim Myers, et al.
Nature Medicine|April 12, 2022
Increased global integration in the brain after psilocybin therapy for depressionRichard E Daws, Christopher Timmermann, Bruna Giribaldi, et al.
Trials|May 24, 2008
GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocolLaura Thomas, Jean Mulligan, Victoria Mason, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 4, 2015
A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based NomenclatureJoseph Zohar, Stephen Stahl, Hans-Jurgen Moller, et al.
Lancet (London, England)|July 24, 2010
Vienna Declaration: a call for evidence-based drug policiesEvan Wood, Dan Werb, Michel Kazatchkine, et al.
Journal of Psychopharmacology (Oxford, England)|July 16, 2019
Microdosing psychedelics: More questions than answers? An overview and suggestions for future researchKim Pc Kuypers, Livia Ng, David Erritzoe, et al.
EJNMMI Physics|March 10, 2016
Assessment of the quality of brain regions and neuroimaging metrics as biomarkers of Alzheimer's DiseaseTânia Faria Vaz, Filipa Lucena, Joana Pé-Leve, et al.
Brain : a Journal of Neurology|September 11, 2019
Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo11C-BU99008 PET studyHeather Wilson, George Dervenoulas, Gennaro Pagano, et al.
Journal of Psychopharmacology (Oxford, England)|July 5, 2019
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An updateSue Wilson, Kirstie Anderson, David Baldwin, et al.
Pageof 18